Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study

Hecht Foundation’s commitment will continue and expand the current NCCAM funded Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study. It will fund the continued collection of clinical, laboratory and quality of life outcomes for the NCCAM-funded case cohort of 300 and their 900 matched controls.  Five years of data on all study participants will create meaningful survival, disease-free and progression free survival Kaplan-Meier curves.  The combined resources of NCCAM and the Hecht Foundation will lead to meaningful insights into the impacts of the merging field of integrative oncology.